Theodore Schroeder
2020
In 2020, Theodore Schroeder earned a total compensation of $1.7M as Chief Executive Officer at Nabriva Therapeutics AG, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $242,256 |
|---|---|
| Option Awards | $339,625 |
| Salary | $576,800 |
| Stock Awards | $464,130 |
| Other | $31,759 |
| Total | $1,654,570 |
Schroeder received $576.8K in salary, accounting for 35% of the total pay in 2020.
Schroeder also received $242.3K in non-equity incentive plan, $339.6K in option awards, $464.1K in stock awards and $31.8K in other compensation.
Rankings
In 2020, Theodore Schroeder's compensation ranked 6,400th out of 13,090 executives tracked by ExecPay. In other words, Schroeder earned more than 51.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,400 out of 13,090 | 51st |
Division Manufacturing | 2,640 out of 5,620 | 53rd |
Major group Chemicals And Allied Products | 1,065 out of 2,253 | 53rd |
Industry group Drugs | 920 out of 1,953 | 53rd |
Industry Pharmaceutical Preparations | 688 out of 1,458 | 53rd |
Source: SEC filing on July 11, 2022.
Schroeder's colleagues
We found one more compensation record of an executive who worked with Theodore Schroeder at Nabriva Therapeutics AG in 2020.
2020
Steven Gelone
Nabriva Therapeutics AG